Skip to main content
Erschienen in: Osteoporosis International 11/2011

01.11.2011 | Position Paper

Towards a diagnostic and therapeutic consensus in male osteoporosis

verfasst von: J. A. Kanis, G. Bianchi, J. P. Bilezikian, J.-M. Kaufman, S. Khosla, E. Orwoll, E. Seeman

Erschienen in: Osteoporosis International | Ausgabe 11/2011

Einloggen, um Zugang zu erhalten

Abstract

Summary

The consensus views on osteoporosis in men are reported.

Introduction

A workshop was convened within a meeting on osteoporosis in men to identify areas of consensus amongst the panel (the authors) and the participants of the meeting.

Methods

A public debate with an expert panel on preselected topics was conducted.

Results and Conclusions

Consensus views were reached on diagnostic criteria and several aspects on the pathophysiology and treatment of osteoporosis in men.
Literatur
1.
Zurück zum Zitat World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical report series 843. WHO, Geneva World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical report series 843. WHO, Geneva
2.
Zurück zum Zitat Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:17–1141 Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:17–1141
3.
Zurück zum Zitat Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ, Khaltaev N (2008) A reference standard for the description of osteoporosis. Bone 42:467–475PubMedCrossRef Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ, Khaltaev N (2008) A reference standard for the description of osteoporosis. Bone 42:467–475PubMedCrossRef
4.
Zurück zum Zitat Kanis JA, Glüer CC, for the Committee of Scientific Advisors, International Osteoporosis Foundation (2000) An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int 11:192–202PubMedCrossRef Kanis JA, Glüer CC, for the Committee of Scientific Advisors, International Osteoporosis Foundation (2000) An update on the diagnosis and assessment of osteoporosis with densitometry. Osteoporos Int 11:192–202PubMedCrossRef
5.
Zurück zum Zitat Melton LJ III, Atkinson EJ, O’Connor MK, O’Fallon WM, Riggs BL (1998) Bone density and fracture risk in men. J Bone Miner Res 13:1915–1923PubMedCrossRef Melton LJ III, Atkinson EJ, O’Connor MK, O’Fallon WM, Riggs BL (1998) Bone density and fracture risk in men. J Bone Miner Res 13:1915–1923PubMedCrossRef
6.
Zurück zum Zitat Melton LJ III, Orwoll ES, Wasnich RD (2001) Does bone density predict fractures comparably in men and women? Osteoporos Int 12:707–709PubMedCrossRef Melton LJ III, Orwoll ES, Wasnich RD (2001) Does bone density predict fractures comparably in men and women? Osteoporos Int 12:707–709PubMedCrossRef
7.
Zurück zum Zitat Cummings SR, Cawthon PM, Ensrud KE et al (2006) BMD and risk of hip and nonvertebral fractures in older men: a prospective study and comparison with older women. J Bone Miner Res 21:1550–6PubMedCrossRef Cummings SR, Cawthon PM, Ensrud KE et al (2006) BMD and risk of hip and nonvertebral fractures in older men: a prospective study and comparison with older women. J Bone Miner Res 21:1550–6PubMedCrossRef
8.
Zurück zum Zitat Johnell O, Kanis JA, Oden A et al (2005) Predictive value of bone mineral density for hip and other fractures. J Bone Miner Res 20:1185–1194PubMedCrossRef Johnell O, Kanis JA, Oden A et al (2005) Predictive value of bone mineral density for hip and other fractures. J Bone Miner Res 20:1185–1194PubMedCrossRef
9.
Zurück zum Zitat Kanis JA, Johnell O, Oden A, De Laet C, Mellstrom D (2001) Diagnosis of osteoporosis and fracture threshold in men. Calcif Tissue Int 69:218–221PubMedCrossRef Kanis JA, Johnell O, Oden A, De Laet C, Mellstrom D (2001) Diagnosis of osteoporosis and fracture threshold in men. Calcif Tissue Int 69:218–221PubMedCrossRef
11.
Zurück zum Zitat Selby PL, Davies M, Adams JE (2000) Do men and women fracture bones at similar bone densities. Osteoporos Int 11:153–157PubMedCrossRef Selby PL, Davies M, Adams JE (2000) Do men and women fracture bones at similar bone densities. Osteoporos Int 11:153–157PubMedCrossRef
12.
Zurück zum Zitat Lunt M, Felsenberg D, Reeve J et al (1997) Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: the EVOS Study. J Bone Miner Res 12:1883–94PubMedCrossRef Lunt M, Felsenberg D, Reeve J et al (1997) Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: the EVOS Study. J Bone Miner Res 12:1883–94PubMedCrossRef
13.
Zurück zum Zitat Nguyen T, Sambrook P, Kelly P et al (1993) Prediction of osteoporotic fractures by postural instability and bone density. Br Med J 307:1111–1115CrossRef Nguyen T, Sambrook P, Kelly P et al (1993) Prediction of osteoporotic fractures by postural instability and bone density. Br Med J 307:1111–1115CrossRef
14.
Zurück zum Zitat DeLaet CED, van Hout BA, Burger H, Hoffman A, Pols HAP (1997) Bone density and risk of hip fracture in men and women: cross sectional analysis. Brit Med J 315:221–225 DeLaet CED, van Hout BA, Burger H, Hoffman A, Pols HAP (1997) Bone density and risk of hip fracture in men and women: cross sectional analysis. Brit Med J 315:221–225
15.
Zurück zum Zitat DeLaet CEDH, Van Hout BA, Burger H, Hofman A, Weel AEAM, Pols HAP (1998) Hip fracture prediction in elderly men and women: validation in the Rotterdam Study. J Bone Miner Res 13:1587–1593CrossRef DeLaet CEDH, Van Hout BA, Burger H, Hofman A, Weel AEAM, Pols HAP (1998) Hip fracture prediction in elderly men and women: validation in the Rotterdam Study. J Bone Miner Res 13:1587–1593CrossRef
16.
Zurück zum Zitat Wasnich RD, Davis JW, Ross PD (1994) Spine fracture risk is predicted by non spine fractures. Osteoporos Int 4:1–5PubMedCrossRef Wasnich RD, Davis JW, Ross PD (1994) Spine fracture risk is predicted by non spine fractures. Osteoporos Int 4:1–5PubMedCrossRef
17.
Zurück zum Zitat Kanis JA, Johnell O, Oden A, Jonsson B, De Laet C, Dawson A (2000) Risk of hip fracture according to World Health Organization criteria for osteoporosis and osteopenia. Bone 27:585–590PubMedCrossRef Kanis JA, Johnell O, Oden A, Jonsson B, De Laet C, Dawson A (2000) Risk of hip fracture according to World Health Organization criteria for osteoporosis and osteopenia. Bone 27:585–590PubMedCrossRef
18.
Zurück zum Zitat Currey JD (2002) Bones: structure and mechanics. Princeton University Press, Princeton, pp 1–380 Currey JD (2002) Bones: structure and mechanics. Princeton University Press, Princeton, pp 1–380
19.
Zurück zum Zitat Parfitt AM (2008) Skeletal heterogeneity and the purposes of bone remodeling: Implications for the understanding of osteoporosis. In: Marcus R, Feldman D, Nelson DA, Rosen CJ (eds) Osteoporosis. Academic, San Diego, pp 71–89CrossRef Parfitt AM (2008) Skeletal heterogeneity and the purposes of bone remodeling: Implications for the understanding of osteoporosis. In: Marcus R, Feldman D, Nelson DA, Rosen CJ (eds) Osteoporosis. Academic, San Diego, pp 71–89CrossRef
20.
Zurück zum Zitat Seeman E, Delmas PD (2006) Bone quality—the material and structural basis of bone strength and fragility. N Engl J Med 354:2250–61PubMedCrossRef Seeman E, Delmas PD (2006) Bone quality—the material and structural basis of bone strength and fragility. N Engl J Med 354:2250–61PubMedCrossRef
21.
Zurück zum Zitat Lips P, Courpron P, Meunier PJ (1978) Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age. Calcif Tissue Res 26:13–7PubMedCrossRef Lips P, Courpron P, Meunier PJ (1978) Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age. Calcif Tissue Res 26:13–7PubMedCrossRef
22.
Zurück zum Zitat Garnero P, Sorney-Rendu E, Duboeuf F, Delmas PD (1999) Markers of bone turnover predict postmenopausal bone loss over 4 years: the OFELY study. J Bone Miner Res 14:1614–21PubMedCrossRef Garnero P, Sorney-Rendu E, Duboeuf F, Delmas PD (1999) Markers of bone turnover predict postmenopausal bone loss over 4 years: the OFELY study. J Bone Miner Res 14:1614–21PubMedCrossRef
23.
Zurück zum Zitat Smith MR, Goode M, Zietman AL, McGovern FJ, Lee H, Finkelstein JS (2004) Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition. J Oncol 22:2546–63CrossRef Smith MR, Goode M, Zietman AL, McGovern FJ, Lee H, Finkelstein JS (2004) Bicalutamide monotherapy versus leuprolide monotherapy for prostate cancer: effects on bone mineral density and body composition. J Oncol 22:2546–63CrossRef
24.
Zurück zum Zitat Balena R, Shih M-S, Parfitt AM (1992) Bone resorption and formation on the periosteal envelope of the ilium: a histomorphometric study in healthy women. J Bone Miner Res 7:1475–1482PubMedCrossRef Balena R, Shih M-S, Parfitt AM (1992) Bone resorption and formation on the periosteal envelope of the ilium: a histomorphometric study in healthy women. J Bone Miner Res 7:1475–1482PubMedCrossRef
25.
Zurück zum Zitat Aaron JE, Makins NB, Sagreiya K (1987) The microanatomy of trabecular bone loss in normal aging men and women. Clin Orthop Relat Res 215:260–71PubMed Aaron JE, Makins NB, Sagreiya K (1987) The microanatomy of trabecular bone loss in normal aging men and women. Clin Orthop Relat Res 215:260–71PubMed
26.
Zurück zum Zitat Zebaze R, Ghasem-Zadeh A, Bohte A et al (2010) Intracortical remodeling and porosity: rational targets for fracture prevention. Lancet 375:1729–36PubMedCrossRef Zebaze R, Ghasem-Zadeh A, Bohte A et al (2010) Intracortical remodeling and porosity: rational targets for fracture prevention. Lancet 375:1729–36PubMedCrossRef
27.
Zurück zum Zitat Burghardt AJ, Buie HR, Laib A, Majumdar S, Boyd SK (2010) Rreproducibility of direct quantitative measures of cortical bone microarchitecture of the distal radius and tibia by HR-pQCT. Bone 47:519–28PubMedCrossRef Burghardt AJ, Buie HR, Laib A, Majumdar S, Boyd SK (2010) Rreproducibility of direct quantitative measures of cortical bone microarchitecture of the distal radius and tibia by HR-pQCT. Bone 47:519–28PubMedCrossRef
28.
Zurück zum Zitat Burghardt AJ, Kazakia GJ, RamachandranS LTM, Majumdar S (2010) Age- and gender-related differences in the geometric properties and biomechanical significance of intracortical porosity in the distal radius and tibia. J Bone Miner Res 25:983–93PubMedCrossRef Burghardt AJ, Kazakia GJ, RamachandranS LTM, Majumdar S (2010) Age- and gender-related differences in the geometric properties and biomechanical significance of intracortical porosity in the distal radius and tibia. J Bone Miner Res 25:983–93PubMedCrossRef
29.
Zurück zum Zitat Bass S, Delmas PD, Pearce G, Hendrich E, Tabensky A, Seeman E (1999) The differing tempo of growth in bone size, mass and density in girls is region-specific. J Clin Invest 104:795–804PubMedCrossRef Bass S, Delmas PD, Pearce G, Hendrich E, Tabensky A, Seeman E (1999) The differing tempo of growth in bone size, mass and density in girls is region-specific. J Clin Invest 104:795–804PubMedCrossRef
30.
Zurück zum Zitat Duan Y, Wang XF, Evans A, Seeman E (2005) Structural and biomechanical basis of racial and sex differences in vertebral fragility in Chinese and Caucasians. Bone 36:987–98PubMedCrossRef Duan Y, Wang XF, Evans A, Seeman E (2005) Structural and biomechanical basis of racial and sex differences in vertebral fragility in Chinese and Caucasians. Bone 36:987–98PubMedCrossRef
31.
Zurück zum Zitat Riggs BL, Melton LJ III, Robb RA et al (2004) A population-based study of age and sex differences in bone volumetric density, size, geometry and structure at different skeletal sites. J Bone Miner Res 19:1945–54PubMedCrossRef Riggs BL, Melton LJ III, Robb RA et al (2004) A population-based study of age and sex differences in bone volumetric density, size, geometry and structure at different skeletal sites. J Bone Miner Res 19:1945–54PubMedCrossRef
32.
Zurück zum Zitat Seeman E (2003) Periosteal bone formation—a neglected determinant of bone strength. N Engl J Med 349:320–3PubMedCrossRef Seeman E (2003) Periosteal bone formation—a neglected determinant of bone strength. N Engl J Med 349:320–3PubMedCrossRef
33.
Zurück zum Zitat Ural A, Vashishth D (2006) Interactions between microstructural and geometrical adaptation in human cortical bone. J Orthop Res 24:1489–98PubMedCrossRef Ural A, Vashishth D (2006) Interactions between microstructural and geometrical adaptation in human cortical bone. J Orthop Res 24:1489–98PubMedCrossRef
34.
Zurück zum Zitat Nalla RK, Kruzic JJ, Kinney JH et al (2010) Role of microstructure in the aging-related deterioration of the toughness of human cortical bone. Mater Sci Eng, C 26:1251–1260CrossRef Nalla RK, Kruzic JJ, Kinney JH et al (2010) Role of microstructure in the aging-related deterioration of the toughness of human cortical bone. Mater Sci Eng, C 26:1251–1260CrossRef
35.
Zurück zum Zitat Yeni YN, Brown CU, Wang Z, Norman TL (1997) The influence of bone morphology on fracture toughness of the human femur and tibia. Bone 21:453–9PubMedCrossRef Yeni YN, Brown CU, Wang Z, Norman TL (1997) The influence of bone morphology on fracture toughness of the human femur and tibia. Bone 21:453–9PubMedCrossRef
36.
Zurück zum Zitat Currey JD (1988) The effect of porosity and mineral content on the Young’s modulus of elasticity of compact bone. J Biomech 21:131–139PubMedCrossRef Currey JD (1988) The effect of porosity and mineral content on the Young’s modulus of elasticity of compact bone. J Biomech 21:131–139PubMedCrossRef
37.
Zurück zum Zitat Ciarelli TE, Fyhrie DP, Parfitt AM (2003) Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females. Bone 32:311–5PubMedCrossRef Ciarelli TE, Fyhrie DP, Parfitt AM (2003) Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females. Bone 32:311–5PubMedCrossRef
38.
Zurück zum Zitat Qiu S, Rao DS, Fyhrie DP, Palnitkar S, Parfitt AM (2005) The morphological association between microcracks and osteocyte lacunae in human cortical bone. Bone 37:10–15PubMedCrossRef Qiu S, Rao DS, Fyhrie DP, Palnitkar S, Parfitt AM (2005) The morphological association between microcracks and osteocyte lacunae in human cortical bone. Bone 37:10–15PubMedCrossRef
39.
Zurück zum Zitat Zebaze R, Seeman E, Ghasem-Zadeh A et al (2010) Analysis system and method. Australian Provisional Patent No. 2009904407 Zebaze R, Seeman E, Ghasem-Zadeh A et al (2010) Analysis system and method. Australian Provisional Patent No. 2009904407
40.
Zurück zum Zitat Saito M, Marumo K (2010) Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int 21:195–214PubMedCrossRef Saito M, Marumo K (2010) Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int 21:195–214PubMedCrossRef
41.
Zurück zum Zitat Tang SY, Zeenath U, Vashishth D (2007) Effects of non-enzymatic glycation on cancellous bone fragility. Bone 40:1144–51PubMedCrossRef Tang SY, Zeenath U, Vashishth D (2007) Effects of non-enzymatic glycation on cancellous bone fragility. Bone 40:1144–51PubMedCrossRef
42.
Zurück zum Zitat Duan Y, Seeman E, Turner CH (2001) The biomechanical basis of vertebral body fragility in men and women. J Bone Miner Res 16:2276–2283PubMedCrossRef Duan Y, Seeman E, Turner CH (2001) The biomechanical basis of vertebral body fragility in men and women. J Bone Miner Res 16:2276–2283PubMedCrossRef
43.
Zurück zum Zitat Orwoll E, Ettinger M, Weiss S et al (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604–610PubMedCrossRef Orwoll E, Ettinger M, Weiss S et al (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604–610PubMedCrossRef
44.
Zurück zum Zitat Ho YV, Frauman AG, Thomson W, Seeman E (2000) Effects of alendronate on bone density in men with primary and secondary osteoporosis. Osteoporos Int 11:98–101PubMedCrossRef Ho YV, Frauman AG, Thomson W, Seeman E (2000) Effects of alendronate on bone density in men with primary and secondary osteoporosis. Osteoporos Int 11:98–101PubMedCrossRef
45.
Zurück zum Zitat Kurland ES, Cosman F, McMahon DJ, Rosen CJ, Lindsay R, Bilezikian JP (2000) Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers. J Clin Endocrinol Metab 85:3069–3076PubMedCrossRef Kurland ES, Cosman F, McMahon DJ, Rosen CJ, Lindsay R, Bilezikian JP (2000) Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers. J Clin Endocrinol Metab 85:3069–3076PubMedCrossRef
46.
Zurück zum Zitat Neer RM, Arnaud CD, Zanchetta JR et al (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Eng J Med 344:1434–1441CrossRef Neer RM, Arnaud CD, Zanchetta JR et al (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Eng J Med 344:1434–1441CrossRef
47.
Zurück zum Zitat Orwoll ES, Scheele WH, Paul S et al (2003) The effect of teriparatide [human parathyroid hormone (1–34)] therapy on bone density in men with osteoporosis. J Bone Miner Res 18:9–17PubMedCrossRef Orwoll ES, Scheele WH, Paul S et al (2003) The effect of teriparatide [human parathyroid hormone (1–34)] therapy on bone density in men with osteoporosis. J Bone Miner Res 18:9–17PubMedCrossRef
48.
Zurück zum Zitat Gonnell S, Cepoliano C, Montagnani A et al (2003) Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study. Calcif Tissue Int 73:133–159CrossRef Gonnell S, Cepoliano C, Montagnani A et al (2003) Alendronate treatment in men with primary osteoporosis: a three-year longitudinal study. Calcif Tissue Int 73:133–159CrossRef
49.
Zurück zum Zitat Drake WM, Kendler DL, Rosen CJ, Orwoll ES (2003) An investigation of the predictors of bone mineral density and response to therapy with alendronate in osteoporotic men. J Clin Endocrinol Metab 88:5759–5765PubMedCrossRef Drake WM, Kendler DL, Rosen CJ, Orwoll ES (2003) An investigation of the predictors of bone mineral density and response to therapy with alendronate in osteoporotic men. J Clin Endocrinol Metab 88:5759–5765PubMedCrossRef
50.
Zurück zum Zitat Miller PD, Schnitzer T, Emkey R et al (2004) Weekly oral alendronic acid in male osteoporosis. Clin Drug Invest 24l:333–341CrossRef Miller PD, Schnitzer T, Emkey R et al (2004) Weekly oral alendronic acid in male osteoporosis. Clin Drug Invest 24l:333–341CrossRef
51.
Zurück zum Zitat Boonen S, Orwoll ES, Wenderoth D, Stoner KJ, Eusebio R, Delmas PD (2009) Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study. J Bone Miner Res 24:719–725PubMedCrossRef Boonen S, Orwoll ES, Wenderoth D, Stoner KJ, Eusebio R, Delmas PD (2009) Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study. J Bone Miner Res 24:719–725PubMedCrossRef
52.
Zurück zum Zitat Ringe JD, Farahmand P, Faber K, Dorst A (2009) Sustained efficacy of risedronate in men with primary and secondary osteporoosis: results of a 2-year study. Rheumatol Int 29:311–315PubMedCrossRef Ringe JD, Farahmand P, Faber K, Dorst A (2009) Sustained efficacy of risedronate in men with primary and secondary osteporoosis: results of a 2-year study. Rheumatol Int 29:311–315PubMedCrossRef
53.
Zurück zum Zitat Orwoll ES, Miller PD, Adachi JD et al (2010) Efficacy and safety of a once-yearly i.v. infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study. J Bone Miner Res 25:2239–2250PubMedCrossRef Orwoll ES, Miller PD, Adachi JD et al (2010) Efficacy and safety of a once-yearly i.v. infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study. J Bone Miner Res 25:2239–2250PubMedCrossRef
54.
Zurück zum Zitat Orwoll ES, Binkley NC, Lweiecki EM, Gruntmanis U, Fries MA, Dasic G (2010) Efficacy and safety of monthly ibandronate in men with low bone density. Bone 46:970–976PubMedCrossRef Orwoll ES, Binkley NC, Lweiecki EM, Gruntmanis U, Fries MA, Dasic G (2010) Efficacy and safety of monthly ibandronate in men with low bone density. Bone 46:970–976PubMedCrossRef
55.
Zurück zum Zitat Boonen S, Kaufman JM, Reginster J-Y et al (2011) Antifracture efficacy and safety of once-yearly zoledronic acid 5 mg in men with osteoporosis: a prospective, randomised, controlled trial. Osteoporos Int 22 (Suppl 1):S180 Boonen S, Kaufman JM, Reginster J-Y et al (2011) Antifracture efficacy and safety of once-yearly zoledronic acid 5 mg in men with osteoporosis: a prospective, randomised, controlled trial. Osteoporos Int 22 (Suppl 1):S180
56.
Zurück zum Zitat Smith MR, Egerdie B, Hernández Toriz N, Denosumab HALT Prostate Cancer Study Group et al (2009) Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med 361:745–55PubMedCrossRef Smith MR, Egerdie B, Hernández Toriz N, Denosumab HALT Prostate Cancer Study Group et al (2009) Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med 361:745–55PubMedCrossRef
57.
Zurück zum Zitat World Health Organization (1998) Guidelines for preclinical evaluation and clinical trials in osteoporosis. WHO, Geneve World Health Organization (1998) Guidelines for preclinical evaluation and clinical trials in osteoporosis. WHO, Geneve
58.
Zurück zum Zitat Lang T, Cauley JA, Tylavsky F, BauerD CS, Harris TB (2010) Computed tomographic measurements of thigh muscle cross-sectional area and attenuation coefficient predict hip fracture: The health, aging, and body composition study. J Bone Miner Res 25:513–519PubMedCrossRef Lang T, Cauley JA, Tylavsky F, BauerD CS, Harris TB (2010) Computed tomographic measurements of thigh muscle cross-sectional area and attenuation coefficient predict hip fracture: The health, aging, and body composition study. J Bone Miner Res 25:513–519PubMedCrossRef
59.
Zurück zum Zitat Lewis CE, Ewing SK, Taylor BC et al (2007) Predictors of non-spine fracture in elderly men: the MrOS study. J Bone Miner Res 22:211–219PubMedCrossRef Lewis CE, Ewing SK, Taylor BC et al (2007) Predictors of non-spine fracture in elderly men: the MrOS study. J Bone Miner Res 22:211–219PubMedCrossRef
60.
Zurück zum Zitat Cummings SR, Nevitt MC, Browner WS et al (1995) Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332:767–773PubMedCrossRef Cummings SR, Nevitt MC, Browner WS et al (1995) Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332:767–773PubMedCrossRef
61.
Zurück zum Zitat Cawthon PM, Fullman RL, Marshall L et al (2008) Physical performance and risk of hip fractures in older men. J Bone Miner Res 23:1037–44PubMedCrossRef Cawthon PM, Fullman RL, Marshall L et al (2008) Physical performance and risk of hip fractures in older men. J Bone Miner Res 23:1037–44PubMedCrossRef
62.
Zurück zum Zitat Michael YL, Whitlock EP, Lin JS, Fu R, O'Connor EA, Gold R (2010) Primary care-relevant interventions to prevent falling in older adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 153:815–825PubMed Michael YL, Whitlock EP, Lin JS, Fu R, O'Connor EA, Gold R (2010) Primary care-relevant interventions to prevent falling in older adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 153:815–825PubMed
63.
Zurück zum Zitat Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B (2006) Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Arch Intern Med 166:424–430PubMedCrossRef Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B (2006) Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Arch Intern Med 166:424–430PubMedCrossRef
64.
Zurück zum Zitat McClung MR, Geusens P, Miller PD et al (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 344:333–340PubMedCrossRef McClung MR, Geusens P, Miller PD et al (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 344:333–340PubMedCrossRef
65.
Zurück zum Zitat De Laet C, Kanis JA, Oden A et al (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16:1330–8PubMedCrossRef De Laet C, Kanis JA, Oden A et al (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16:1330–8PubMedCrossRef
66.
Zurück zum Zitat Flegal KM, Carroll MD, Ogden CL et al (2010) Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303:235–41PubMedCrossRef Flegal KM, Carroll MD, Ogden CL et al (2010) Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303:235–41PubMedCrossRef
67.
Zurück zum Zitat Sundquist J, Johnansson S-E, Sundquist K (2010) Levelling off of prevalence of obesity in the adult population of Sweden between 2000/01 and 2004/05. BMC Public Health 2010:10 Sundquist J, Johnansson S-E, Sundquist K (2010) Levelling off of prevalence of obesity in the adult population of Sweden between 2000/01 and 2004/05. BMC Public Health 2010:10
68.
Zurück zum Zitat Nielson CM, Marshall LM, Adams AL et al (2010) BMI and fracture risk in older men: the osteoporotic fractures in men (MrOS) study. J Bone Miner Res 26(3):496–502CrossRef Nielson CM, Marshall LM, Adams AL et al (2010) BMI and fracture risk in older men: the osteoporotic fractures in men (MrOS) study. J Bone Miner Res 26(3):496–502CrossRef
69.
Zurück zum Zitat Freitas SS, Barrett-Connor E, Ensrud KE et al (2008) Rate and circumstances of clinical vertebral fractures in older men. Osteoporos Int 19:615–623PubMedCrossRef Freitas SS, Barrett-Connor E, Ensrud KE et al (2008) Rate and circumstances of clinical vertebral fractures in older men. Osteoporos Int 19:615–623PubMedCrossRef
71.
Zurück zum Zitat Peacock M, Koller DL, Lai D, Hui S, Foroud T, Econs MJ (2009) Bone mineral density variation in men is influenced by sex-specific and non sex-specific quantitative trait loci. Bone 45:443–448PubMedCrossRef Peacock M, Koller DL, Lai D, Hui S, Foroud T, Econs MJ (2009) Bone mineral density variation in men is influenced by sex-specific and non sex-specific quantitative trait loci. Bone 45:443–448PubMedCrossRef
72.
Zurück zum Zitat Khosla S, Melton LJ III, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL (1998) Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 83:2266–2274PubMedCrossRef Khosla S, Melton LJ III, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL (1998) Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 83:2266–2274PubMedCrossRef
73.
Zurück zum Zitat Rapado A, Hawkins F, Sobrinho L et al (1999) Bone mineral density and androgen levels in elderly males. Calcif Tissue Int 65:417–21PubMedCrossRef Rapado A, Hawkins F, Sobrinho L et al (1999) Bone mineral density and androgen levels in elderly males. Calcif Tissue Int 65:417–21PubMedCrossRef
74.
Zurück zum Zitat Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S (2000) Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106:1553–1560PubMedCrossRef Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S (2000) Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 106:1553–1560PubMedCrossRef
75.
Zurück zum Zitat Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS (2003) Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab 88:204–210PubMedCrossRef Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS (2003) Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab 88:204–210PubMedCrossRef
76.
Zurück zum Zitat Khosla S, Melton LJ, Atkinson EJ, O'Fallon WM (2001) Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab 86:3555–3561PubMedCrossRef Khosla S, Melton LJ, Atkinson EJ, O'Fallon WM (2001) Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab 86:3555–3561PubMedCrossRef
77.
Zurück zum Zitat Van Pottelbergh I, Goemaere S, Kaufman JM (2003) Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age. J Clin Endocrinol Metab 88:3075–3081PubMedCrossRef Van Pottelbergh I, Goemaere S, Kaufman JM (2003) Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age. J Clin Endocrinol Metab 88:3075–3081PubMedCrossRef
78.
Zurück zum Zitat Lapauw B, Taes Y, Goemaere S, Toye K, Zmierczak H-G, Kaufman J-M (2009) Anthropometric and skeletal phenotype in men with idiopathic osteoporosis and their sons is consistent with deficient estrogen action during maturation. J Clin Endocrinol Metab 94:4300–4308PubMedCrossRef Lapauw B, Taes Y, Goemaere S, Toye K, Zmierczak H-G, Kaufman J-M (2009) Anthropometric and skeletal phenotype in men with idiopathic osteoporosis and their sons is consistent with deficient estrogen action during maturation. J Clin Endocrinol Metab 94:4300–4308PubMedCrossRef
79.
Zurück zum Zitat Khosla S, Melton LJ, Riggs BL (2002) Estrogen and the male skeleton. J Clin Endocrinol Metab 87:1443–1450PubMedCrossRef Khosla S, Melton LJ, Riggs BL (2002) Estrogen and the male skeleton. J Clin Endocrinol Metab 87:1443–1450PubMedCrossRef
80.
Zurück zum Zitat Mellstrom D, Vandenput L, Mallmim H et al (2008) Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. J Bone Miner Res 23:1552–1560PubMedCrossRef Mellstrom D, Vandenput L, Mallmim H et al (2008) Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. J Bone Miner Res 23:1552–1560PubMedCrossRef
81.
Zurück zum Zitat Riggs BL, Melton LJ (1986) Medical progress series: involutional osteoporosis. N Engl J Med 314:1676–1686PubMedCrossRef Riggs BL, Melton LJ (1986) Medical progress series: involutional osteoporosis. N Engl J Med 314:1676–1686PubMedCrossRef
82.
Zurück zum Zitat Smith MR (2007) Androgen deprivation therapy for prostate cancer: new concepts and concerns. Curr Opin Endocrinol Diab Obes 14:247–254CrossRef Smith MR (2007) Androgen deprivation therapy for prostate cancer: new concepts and concerns. Curr Opin Endocrinol Diab Obes 14:247–254CrossRef
83.
Zurück zum Zitat Lowe H, Shane E (2008) Osteoporosis associated with illnesses and medications. In: Marcus R, Feldman D, Nelson DA, Rosen CJ (eds) Osteoporosis. Elsevier, San Diego, pp 1283–1314CrossRef Lowe H, Shane E (2008) Osteoporosis associated with illnesses and medications. In: Marcus R, Feldman D, Nelson DA, Rosen CJ (eds) Osteoporosis. Elsevier, San Diego, pp 1283–1314CrossRef
84.
Zurück zum Zitat Stepan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ (1989) Castrated men exhibit bone loss—effect of calcitonin treatment on biochemical indexes of bone remodeling. J Clin Endocrinol Metab 69:523–527PubMedCrossRef Stepan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ (1989) Castrated men exhibit bone loss—effect of calcitonin treatment on biochemical indexes of bone remodeling. J Clin Endocrinol Metab 69:523–527PubMedCrossRef
85.
Zurück zum Zitat Stoch SA, Parker RA, Chen LP, Bubley G, KO YJ, Vincelette A, Greenspan SL (2001) Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab 86:2787–2791PubMedCrossRef Stoch SA, Parker RA, Chen LP, Bubley G, KO YJ, Vincelette A, Greenspan SL (2001) Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab 86:2787–2791PubMedCrossRef
86.
Zurück zum Zitat Mittan D, Lee S, Miller E, Perez RC, Basler JW, Bruder JM (2002) Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs. J Clin Endocrinol Metab 87:3656–3661PubMedCrossRef Mittan D, Lee S, Miller E, Perez RC, Basler JW, Bruder JM (2002) Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs. J Clin Endocrinol Metab 87:3656–3661PubMedCrossRef
87.
Zurück zum Zitat Shahinian VB, Kuo Y, Freeman JL, Goodwin JS (2005) Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 352:154–164PubMedCrossRef Shahinian VB, Kuo Y, Freeman JL, Goodwin JS (2005) Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 352:154–164PubMedCrossRef
88.
Zurück zum Zitat Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C (2004) Androgens and bone. Endocr Rev 25:389–425PubMedCrossRef Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C (2004) Androgens and bone. Endocr Rev 25:389–425PubMedCrossRef
89.
Zurück zum Zitat Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM (2006) Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 91:1995–2010PubMedCrossRef Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM (2006) Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 91:1995–2010PubMedCrossRef
90.
Zurück zum Zitat Behre HM, Kliesch S, Leifke E, Link TM, Nieschlag E (1997) Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 82:2386–2390PubMedCrossRef Behre HM, Kliesch S, Leifke E, Link TM, Nieschlag E (1997) Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 82:2386–2390PubMedCrossRef
91.
Zurück zum Zitat Crawford BA, Liu PY, Kean MT, Bleasel JF, Handelsman DJ (2003) Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment. J Clin Endocrinol Metab 88:3167–3176PubMedCrossRef Crawford BA, Liu PY, Kean MT, Bleasel JF, Handelsman DJ (2003) Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment. J Clin Endocrinol Metab 88:3167–3176PubMedCrossRef
92.
Zurück zum Zitat Smith MR, Fallon MA, Lee H, Finkelstein JS (2004) Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial. J Clin Endocrinol Metab 89:3841–3846PubMedCrossRef Smith MR, Fallon MA, Lee H, Finkelstein JS (2004) Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial. J Clin Endocrinol Metab 89:3841–3846PubMedCrossRef
93.
Zurück zum Zitat Michaelson MD, Kaufman DS, Lee H et al (2007) Randomized controlled trial of annual zoledronic acidto prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostatz cancer. J Clin Oncol 25:1038–1042PubMedCrossRef Michaelson MD, Kaufman DS, Lee H et al (2007) Randomized controlled trial of annual zoledronic acidto prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostatz cancer. J Clin Oncol 25:1038–1042PubMedCrossRef
94.
Zurück zum Zitat Greenspan SL, Nelson JB, Trump DL, Resnick NM (2007) Effect of once weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for non-metastatic prostate cancer. Ann Intern Med 146:416–424PubMed Greenspan SL, Nelson JB, Trump DL, Resnick NM (2007) Effect of once weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for non-metastatic prostate cancer. Ann Intern Med 146:416–424PubMed
95.
Zurück zum Zitat Kaufman JM, Vermeulen A (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26:833–876PubMedCrossRef Kaufman JM, Vermeulen A (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26:833–876PubMedCrossRef
96.
Zurück zum Zitat Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V, Isidori A, Lenzi A, Fabbri A (2005) Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta analysis. Clin Endocrinol (oxf) 63:280–293CrossRef Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V, Isidori A, Lenzi A, Fabbri A (2005) Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta analysis. Clin Endocrinol (oxf) 63:280–293CrossRef
97.
Zurück zum Zitat Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh I, Holmes JH, Dlewati A, Staley J, Santanna J, Kapoor SC, Attie MF, Haddad JG Jr, Strom BL (1999) Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 84:1966–1972PubMedCrossRef Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh I, Holmes JH, Dlewati A, Staley J, Santanna J, Kapoor SC, Attie MF, Haddad JG Jr, Strom BL (1999) Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 84:1966–1972PubMedCrossRef
98.
Zurück zum Zitat Amory JK, Watts NB, Easley KA, Sutton PR, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL (2004) Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab 89:503–510PubMedCrossRef Amory JK, Watts NB, Easley KA, Sutton PR, Anawalt BD, Matsumoto AM, Bremner WJ, Tenover JL (2004) Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab 89:503–510PubMedCrossRef
99.
Zurück zum Zitat Fernandez-Balsells MM, Murad MH, Lane M et al (2010) Adverse efects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab 95:2560–2575PubMedCrossRef Fernandez-Balsells MM, Murad MH, Lane M et al (2010) Adverse efects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab 95:2560–2575PubMedCrossRef
100.
Zurück zum Zitat Basaria S, Coviello AD, Travison TG et al (2010) Adverse events associated with testosterone administration. N Engl J Med 363:109–122PubMedCrossRef Basaria S, Coviello AD, Travison TG et al (2010) Adverse events associated with testosterone administration. N Engl J Med 363:109–122PubMedCrossRef
101.
Zurück zum Zitat Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, Morley JE, Schulman C, Thompson IM, Weidner W, Wu FC (2008) Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 159:507–14PubMedCrossRef Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, Morley JE, Schulman C, Thompson IM, Weidner W, Wu FC (2008) Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 159:507–14PubMedCrossRef
Metadaten
Titel
Towards a diagnostic and therapeutic consensus in male osteoporosis
verfasst von
J. A. Kanis
G. Bianchi
J. P. Bilezikian
J.-M. Kaufman
S. Khosla
E. Orwoll
E. Seeman
Publikationsdatum
01.11.2011
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 11/2011
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-011-1632-z

Weitere Artikel der Ausgabe 11/2011

Osteoporosis International 11/2011 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.